Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease

PURPOSE: To evaluate the role of Decitabine in the allo-HSCT conditioning regimen for intermediate- and high-risk patients with MDS or AML. PATIENTS AND METHODS: Retrospective analysis of data pertaining to 76 intermediate- and high-risk patients with MDS or AML who underwent allo-HSCT between Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qing Ya, Li, Yuan, Liang, Ze Yin, Yin, Yue, Liu, Wei, Wang, Qian, Dong, Yu Jun, Sun, Yu Hua, Xu, Wei Lin, Ren, Han Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900353/
https://www.ncbi.nlm.nih.gov/pubmed/31824191
http://dx.doi.org/10.2147/CMAR.S229768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900353/
https://www.ncbi.nlm.nih.gov/pubmed/31824191
http://dx.doi.org/10.2147/CMAR.S229768

Ejemplares similares